From agammaglobulinemia to neutropenia: ‘The TCF ‐3 has different clinical presentations’
Scandinavian Journal of Immunology · 2024
DOI: 10.1111/sji.13423 ↗Kurz gefasst
Leserbrief in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Hulya Kose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Allergy, Diyarbakir Children's Hospital, Diyarbakir, Turkey. Hauptthemen laut MEDLINE: Neutropenia, Agammaglobulinemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Immunology and Allergy, Diyarbakir Children's Hospital, Diyarbakir, Turkey.
- Department of Pediatric Genetics, Diyarbakir Children's Hospital, Diyarbakir, Turkey.
- Department of Pediatric Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
ORCID-Profile: Hulya Kose, Sara Sebnem Kilic
Zitieren
APA
Kose, H., Akalin, A., & Kilic, S. S. (2024). From agammaglobulinemia to neutropenia: ‘The TCF ‐3 has different clinical presentations’. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13423
Vancouver
Kose H, Akalin A, Kilic SS. From agammaglobulinemia to neutropenia: ‘The TCF ‐3 has different clinical presentations’. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13423
BibTeX
@article{Kose2024,
author = {Kose, Hulya and Akalin, Akcahan and Kilic, Sara Sebnem},
title = {From agammaglobulinemia to neutropenia: ‘The TCF ‐3 has different clinical presentations’},
journal = {Scandinavian Journal of Immunology},
year = {2024},
doi = {10.1111/sji.13423}
}
EUVIMED